Form 25-NSE ASTRAZENECA PLC Filed by: NEW YORK STOCK EXCHANGE LLC
Tweet
Share
E-mailSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NS
- Rato Communications Introduces HACK Framework
- Push Security Delivers Browser-Native Security as Direct Alternative to SWG and CASB, Targeting the Attacks Proxy-Based Tools Can't See
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
